The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Zydus faces stiff competition for blockbuster drug in US from Teva Pharma | Business Standard News
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
Teva seeks blockbuster drug to succeed Copaxone - Globes
Teva Pharmaceutical to lay off 14,000 globally; effect on Gurnee facility unclear - Chicago Tribune
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva share price zooms - Globes
Teva Finally Wins FDA Approval for Potential Huntington's Blockbuster Austedo | BioSpace
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 | Reuters
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
FDA Approves Generic Version Of Teva's Blockbuster Drug - Drug Discovery and Development
5 Biggest Blockbuster Drugs of the Future | The Motley Fool
Teva down as it reports lower sales and profit for 2018
Teva, the world's largest generic drugmaker, is cutting 14,000 workers - Los Angeles Times
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva's Blockbuster Drug Takes Another Generic Blow | Ctech
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Sex, drugs, and sharing trade secrets
Investigation shows Celgene, Teva plotted to keep drug prices high
